Plasma Volume Changes May Mediate Effects of Empagliflozin
Findings suggest reduced CV mortality risk mediated by effects on markers of plasma volume
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news
More News: Cardiology | Empagliflozin | Endocrinology | Geriatrics | Heart | Internal Medicine | Jardiance | Nurses | Nursing | Pathology | Respiratory Medicine